Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06928116 · ClinicalTrials.gov registry record · NA
Heat thErapy And mobiLity in COVID-19 Survivors
A NA study of Long COVID, sponsored by University of Nebraska.
- Recruiting
- Registry status
- NA
- Development phase
- 99
- Enrollment target
- 1
- Study location
NCT06928116: Recruiting NA study of Long COVID, sponsored by University of Nebraska.
NCT06928116 is a NA study of Long COVID that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 99 participants, below the 2,186-participant average among 50 other Long COVID trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06928116, a NA study of Long COVID, is actively recruiting participants, sponsored by University of Nebraska.
- RECRUITING
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
- 1
- Study location
Study Summary
Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restore functional capacity, it may not be feasible or enticing to many people with PASC. This clinical trial seeks to establish the tolerability and efficacy of at home lower-body heat therapy for improving functional capacity along with metabolic and vascular health in late-middle aged and older adults with PASC, also known as "long COVID".
Primary Outcome
Distance covered during 6 min of walking
Conditions Studied
Interventions
- BEHAVIORAL Sham Control
- BEHAVIORAL Walking
- BEHAVIORAL Heat therapy
Study Locations (1)
Nebraska
- University of Nebraska Omaha - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2025-09-17 |
| Est. Completion | 2029-08 |
| Phase | NA |
What NCT06928116 shows while recruiting
NCT06928116 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 2,186-participant average among 50 other Long COVID trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 3 interventions - of which Sham Control is the first listed.
NCT06928116 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT06928116 about?
NCT06928116 is a clinical study titled "Heat thErapy And mobiLity in COVID-19 Survivors". Post-acute sequelae of SARS-CoV-2 infection (PASC) is becoming a major risk factor for chronic diseases, with older adults and those with underlying health conditions at risk of developing persistent mobility limitations and disabilities. Although exercise intervention is a common strategy to restor...
What is the current status of trial NCT06928116?
This trial is currently recruiting. It is a NA study. The enrollment target is 99 participants. The study started on 2025-09-17. Estimated completion is 2029-08.
What conditions does trial NCT06928116 study?
This clinical trial studies the following conditions: Long COVID.
What interventions are being tested in trial NCT06928116?
The interventions under investigation include: Sham Control (BEHAVIORAL), Walking (BEHAVIORAL), Heat therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT06928116?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06928116 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Long COVID
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06928116's enrollment target sits among peer trials
99 25th of 50 higher than 26 of 50 other Long COVID trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Long COVID trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Water-based Activity to Enhance Recovery in Long COVID-19
RECRUITING · NA
-
Non-invasive Treatment for Long COVID (Post COVID-19 Condition) Brain Fog
RECRUITING · NA
-
Long-Covid-19 Alleviation Through Learning Mindfulness Study
RECRUITING · NA
-
Sauna for Long Covid
RECRUITING · NA
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI